Compare RIO & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RIO | BME |
|---|---|---|
| Founded | 1873 | N/A |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Trusts Except Educational Religious and Charitable |
| Sector | Basic Materials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 140.3B | 547.5M |
| IPO Year | N/A | 2005 |
| Metric | RIO | BME |
|---|---|---|
| Price | $89.79 | $39.88 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $81.00 | N/A |
| AVG Volume (30 Days) | ★ 2.8M | 35.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 4.41% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.40 | N/A |
| Revenue Next Year | $2.80 | N/A |
| P/E Ratio | $15.76 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $51.67 | $34.18 |
| 52 Week High | $101.53 | $42.74 |
| Indicator | RIO | BME |
|---|---|---|
| Relative Strength Index (RSI) | 42.36 | 26.59 |
| Support Level | $80.33 | $39.81 |
| Resistance Level | $100.93 | $40.70 |
| Average True Range (ATR) | 1.94 | 0.61 |
| MACD | -1.07 | -0.25 |
| Stochastic Oscillator | 16.98 | 9.81 |
Rio Tinto is a global diversified miner. Iron ore is the dominant commodity, with significantly lesser contributions from copper, aluminum, diamonds, gold, and industrial minerals. The 1995 merger of RTZ and CRA, via a dual-listed structure, created the present-day company. The two operate as a single business entity, with shareholders in each company having equivalent economic and voting rights. Major assets included the Pilbara iron ore operations, a 30% stake in the Escondida copper mine, 66%-ownership of the Oyu Tolgoi copper mine in Mongolia, the Weipa and Gove bauxite mines in Australia, and six hydro-powered aluminum smelters in Canada.
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.